Amylyx Pharmaceuticals, Inc. · NASDAQ:AMLX
Perceptive Advisors LLC reported a 8.80% stake in Amylyx Pharmaceuticals, Inc. (Schedule 13G/A)
Event Mar 31, 2025 · Filed May 15, 2025
Perceptive Advisors LLC reported a 8.80% stake in Amylyx Pharmaceuticals, Inc., 7,874,348 shares, as a passive investor on Mar 31, 2025. Filed May 15, 2025 (Schedule 13G/A).
- Stake
- 8.80%
- Shares
- 7,874,348
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Perceptive Advisors LLC | 8.80% | 7,874,348 |
| Joseph Edelman | 8.80% | 7,874,348 |
| Perceptive Life Sciences Master Fund, Ltd. | 8.80% | 7,874,348 |
Source
Related
- Amylyx Pharmaceuticals, Inc.
- Perceptive Advisors LLC
- Amylyx Pharmaceuticals, Inc. shareholders
- Schedule 13G/A · Perceptive Advisors LLC · May 15, 2026
- Schedule 13G/A · Perceptive Advisors LLC · Nov 14, 2025
- Schedule 13G/A · Perceptive Advisors LLC · Feb 14, 2025
- Form 4 · Milne George M Jr · Oct 7, 2026
- Form 4 · Bedrosian Camille L · Sep 14, 2026
- Form 4 · Frates James M · Sep 14, 2026
- Form 4 · Mazzariello Gina · Sep 14, 2026
- Form 4 · Cohen Joshua B · Sep 14, 2026